Cargando…
Glycosylated hemoglobin A1c predicts coronary artery disease in non‐diabetic patients
BACKGROUND: In primary care, there is a need for simple and cost‐effective tool that will allow the determination of the risk of coronary artery disease (CAD). We aimed to research the value of glycosylated hemoglobin (HbA1c) in the prediction of coronary artery disease. METHODS: Patients admitted t...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891500/ https://www.ncbi.nlm.nih.gov/pubmed/33034919 http://dx.doi.org/10.1002/jcla.23612 |